中国P站

Natural language processing; Electronic health records; Social determinants of health; Kidney transplant; Health disparities; Predictive modeling; Healthcare equity; Data mining; Transplant eligibility; Artificial intelligence; Patient outcomes; EHR analysis; Disparities in healthcare; Clinical decision-making; Access to healthcare

Introduction

Social determinants of health (SDOH) have long been recognized as key factors influencing health outcomes, yet their role in kidney transplant eligibility has been underexplored. SDOH, such as socioeconomic status, education, housing, and access to healthcare, can substantially impact whether a patient is considered for the transplant waitlist. Traditionally, kidney transplant eligibility has been assessed primarily through clinical factors like glomerular filtration rate (GFR) and other biomarker measurements [1-5]. However, these clinical evaluations often overlook the crucial role that social factors play in determining a patient's health and ability to access care. Electronic health records (EHRs), which contain a wealth of clinical and demographic data, can serve as a powerful tool to explore the influence of SDOH on transplant eligibility. By applying natural language processing (NLP) to EHR data, healthcare providers can analyze unstructured text—such as physician notes, patient histories, and other narrative data— to uncover hidden patterns and disparities in kidney transplant evaluations. This approach offers the potential to better understand how SDOH affect the transplant decision-making process and, ultimately, promote more equitable healthcare outcomes [6-10].

Discussion

Natural language processing (NLP) is an advanced subset of artificial intelligence (AI) that enables the extraction of meaningful information from unstructured text within EHRs. This method allows healthcare providers to systematically analyze large volumes of patient data, identifying subtle factors that may influence kidney transplant eligibility. For instance, physician notes often contain valuable insights into a patient’s socioeconomic challenges, such as job instability, housing insecurity, or lack of transportation, which could significantly affect their ability to attend regular medical appointments, adhere to post-transplant care regimens, or even follow through with necessary pre-transplant evaluations. These aspects, which may be underreported or omitted in structured clinical data, can directly impact the patient’s suitability for a transplant.

Through NLP, these unstructured data points can be extracted, categorized, and analyzed to identify patterns in the way SDOH affect eligibility decisions. For example, NLP can detect mentions of social or financial barriers that may delay a patient’s listing for a kidney transplant, or reveal hidden biases that influence clinical decision-making. Studies have shown that factors like education, employment status, and geographic location often correlate with kidney transplant access and outcomes. However, many of these factors are buried within the narrative sections of EHRs and are not systematically integrated into clinical decision tools. By using NLP, clinicians can better incorporate these social factors into their decision-making processes, allowing for more holistic and accurate assessments of transplant eligibility.

Another important aspect of this approach is its potential to uncover healthcare disparities that may otherwise go unnoticed. For example, patients from lower socioeconomic backgrounds may face significant barriers in accessing healthcare resources, resulting in late referrals to transplant centers or delays in receiving appropriate treatments for kidney disease. In some cases, these disparities can lead to worse health outcomes or missed opportunities for transplant, despite meeting clinical criteria. By analyzing EHRs with NLP, it is possible to identify trends in care that disproportionately affect marginalized populations, such as racial or ethnic minorities, or those living in rural areas, who may face additional barriers to transplant eligibility. This approach can also highlight how institutional biases, whether implicit or explicit, influence transplant decision-making, thereby contributing to healthcare inequality.

Despite its potential, the use of NLP in analyzing SDOH in kidney transplant eligibility does come with challenges. One concern is the quality and consistency of EHR data. EHR systems often use different formats, and the data quality may vary depending on the institution, leading to inconsistencies in the information available for analysis. Additionally, NLP algorithms require careful training to ensure they accurately interpret clinical language, which can vary widely between practitioners. Misinterpretations could lead to erroneous conclusions or missed opportunities to identify critical factors impacting transplant eligibility.

Moreover, ethical concerns arise regarding the use of AI and NLP in clinical decision-making. Ensuring that algorithms do not perpetuate existing biases is essential to avoid exacerbating health disparities. For instance, if an NLP model is trained on biased data, it may reinforce systemic inequities rather than uncovering them. Transparent model development, validation, and continuous monitoring are necessary to mitigate such risks. Ensuring that these tools are used to promote equity, rather than inadvertently reinforcing inequalities, requires collaboration between clinicians, data scientists, ethicists, and policymakers.

Conclusion

Natural language processing offers an innovative way to analyze the impact of social determinants of health on kidney transplant eligibility, providing deeper insights into the factors influencing transplant decision-making. By leveraging unstructured data in EHRs, NLP can uncover hidden disparities in access to care and highlight the influence of socioeconomic factors on patient outcomes. While the potential of this technology is vast, challenges related to data quality, algorithmic bias, and ethical considerations must be addressed to ensure it benefits all patients equitably. Ultimately, NLP can be a powerful tool in promoting more inclusive and transparent decision-making in kidney transplant evaluations, facilitating the identification and mitigation of disparities that have long hindered access to life-saving treatments. As the field of AI continues to evolve, the integration of NLP into clinical practice could help to ensure that all patients, regardless of their social circumstances, have a fair opportunity to receive a kidney transplant.

References

1. Delgado JF, Reyne AG, Dios S, López-Medrano F, Jurado A, et al. (2015) Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation. J Heart Lung Transplant 3:1112-1119.

   Indexed at, Google Scholar, Crossref

2. Raffa GM, Di Gesaro G, Sciacca S, Tuzzolino F, Turrisi M, et al. (2016) Heart transplant program at IRCCS-ISMETT: Impact of mechanical circulatory support on pre- and post -transplant survival. Int J Cardiol 219: 358-361.

   Indexed at, Google Scholar, Crossref

3. Zieli艅ska K, Kukulski L, Wróbel M, Przyby艂owski P, Rokicka D, et al. (2022) Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in Heart Transplant Patients According to the Grading Scheme Developed by the International Society for Heart and Lung Transplantation (ISHLT). Ann Transplant 27: 933420.

   Indexed at, Google Scholar, Crossref

4. Conway J, Manlhiot C, Kirk R, Edwards LB, McCrindle BW, et al. Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 33: 241-51.

   Indexed at, Google Scholar, Crossref

5. Vanderlaan RD, Manlhiot C, Edwards LB, Conway J, McCrindle BW, et al. (2015) Risk factors for specific causes of death following pediatric heart transplant: An analysis of the registry of the International Society of Heart and Lung Transplantation. Pediatr Transplant 19: 896-905.

   Indexed at, Google Scholar, Crossref

6. Kitamura S (2012) Heart transplantation in Japan: a critical appraisal for the results and future prospects. Gen Thorac Cardiovasc Surg 60: 639-644.

   Indexed at, Google Scholar, Crossref

7. Wever-Pinzon O, Edwards LB, Taylor DO, Kfoury AG, Drakos SG, et al. (2017) Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant 36: 407-417.

   Indexed at, Google Scholar, Crossref

8. Saczkowski R, Dacey C, Bernier PL (2010) Does ABO-incompatible and ABO-compatible neonatal heart transplant have equivalent survival. Interact Cardiovasc Thorac Surg 10: 1026-1033.

   Indexed at, Google Scholar, Crossref

9. Jeewa A, Manlhiot C, Kantor PF, Mital S, McCrindle BW, et al. (2014) Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list. J Thorac Cardiovasc Surg 147: 462-468.

   Indexed at, Google Scholar, Crossref

10. Sivathasan C, Lim CP, Kerk KL, Sim DK, Mehra MR, et al. (2017) Mechanical circulatory support and heart transplantation in the Asia Pacific region. J Heart Lung Transplant 36: 13-18.

    Indexed at, Google Scholar, Crossref